CCRP AACVPR with 842 complete
solutions all verified and approved.
How |are |lipids |carried |- |ANSWER |on |lipoproteins |in |the |blood |because |they |are |insoluble |in |water
Proteins |found |on |lipoproteins |- |ANSWER |apolipoproteins
Density |of |lipoprotein |with |less |lipid |and |greater |protein |- |ANSWER |more |dense
Density |of |lipoprotein |with |more |lipids |and |less |protein |- |ANSWER |less |dense
Major |bloodstream |lipoproteins |- |ANSWER |chylomicrons, |vLDL, |LDL, |HDL
Chylomicrons |- |ANSWER |least |dense |of |the |lipoproteins |and |are |triglyceride-rich |particles |that |are
|formed |in |the |intestine
Function |of |Chylomicrons |and |where |they |can |be |found |- |ANSWER |Transport |dietary |fat |and |can |be
|found |in |the |bloodstream |at |highest |concentration |soon |after |a |meal
Least |to |most |dense |lipoprotein |particles |- |ANSWER |Chlyomicron, |vLDL, |LDL, |HDL
lipoprotein |that |is |the |most |atherogenic |of |all |lipoproteins |- |ANSWER |LDL
LDL |carries |- |ANSWER |60-70% |of |the |cholesterol |in |the |blood
HDL |carries |- |ANSWER |20-30% |of |the |cholesterol |in |the |blood
Equation |for |total |LDL-C |in |bloodstream |- |ANSWER |LDL= |TC-(HDL-C-(TG/5))
,When |does |calculating |LDL-C |become |inaccurate |- |ANSWER |when |TG |exceeds |400mg/dL
Desirable |total |cholesterol |level |- |ANSWER |<200
Borderline |high |total |cholesterol |level |- |ANSWER |200-240
High |total |cholesterol |level |- |ANSWER |>240
Optimal |TG |level |- |ANSWER |<150
Borderline |high |TG |level |- |ANSWER |150-199
High |TG |level |- |ANSWER |200-499
Very |high |TG |levels |- |ANSWER |>500
Optimal |in |men |HDL |levels |- |ANSWER |>40
Optimal |in |women |HDL |levels |- |ANSWER |>50
Optimal |LDL-C |levels |- |ANSWER |<100
Near |optimal |LDL-C |levels |- |ANSWER |100-129
Borderline |high |LDL-C |levels |- |ANSWER |130-159
,High |LDL-C |levels |- |ANSWER |160-189
Very |high |LDL-C |levels |- |ANSWER |>190
Hypertriglycerdemia |is |associated |with |high |levels |of |- |ANSWER |VLDL-C
Non-HDL-Cholesterol |calculation |- |ANSWER |HDL-C |- |Total |cholesterol
Atherogenic |dyslipidemia |- |ANSWER |Elevated |levels |of |TG, |low |HDL-C |and |only |modest |elevations |of
|LDL- |C
Metabolic |syndrome |- |ANSWER |requires |the |presence |of |any |3 |of |the |following |conditions: |abdominal
|obesity, |elevated |TG, |low |HDL, |elevated |BP |and |hyperglycemia
Criteria |for |metabolic |syndrome: |Abdominal |obesity |- |ANSWER |WC |>102 |cm |(40 |in) |for |men
WC |>88cm |(35 |in) |for |women
|
Criteria |for |metabolic |syndrome: |Hypertriglyceremia |- |ANSWER |≥150 |or |drug |treatment
Criteria |for |metabolic |syndrome: |Low |HDL |- |ANSWER |<40 |for |men
<50 |for |women
Criteria |for |metabolic |syndrome: |Elevated |BP |- |ANSWER |SBP
≥130 |DBP |≥85
|
or |drug |treatment
Criteria |for |metabolic |syndrome: |Hyperglycemia |- |ANSWER |Fasting |glucose |≥100
or |drug |treatment
|
, AACVPR |understanding |of |atherosclerosis |- |ANSWER |Traditional |risk |factors |are |a |source |of
|inflammatory |changes |in |the |blood |vessel |wall |--> |which |attract |lipid |laden |macrophages |and |other
|inflammatory |cells |to |enter |the |blood |vessel |wall |--> |where |they |proliferate |and |develop
|atherosclerotic |plaques |--> |which |are |the |source |of |the |clinical |manifestations |of |CHD
Fatty |streaks |- |ANSWER |lipid |deposition |(daily |lipid |laden |macrophages) |in |the |arterial |wall
Lumen |- |ANSWER |opening |inside |of |the |blood |vessel
fibrous |plaque |- |ANSWER |Larger |and |more |obstructive |lesoions |consisting |of |an |outer |fibrous
Why |do |plaque |ruptures |occurs |prior |to |the |development |of |cardiovascular |symptoms |in |many |cases |-
|ANSWER |Atherosclerotic |plaques |that |are |prone |to |rupture |tend |to |be |younger, |more |immature
|plaques |that |usually |do |not |produce |the |degree |of |luminal |narrowing |required |to |develop |exertion
|symptoms
What |occurs |after |a |plaque |rupture |- |ANSWER |Clot |formation |within |the |lumen |of |the |coronary
|artery, |potential |resulting |in |an |acute |coronary |syndrome |from |the |sudden |development |of |severe
|obstruction |to |coronary |blood |flow
Examples |of |foods |high |in |dietary |cholesterol |- |ANSWER |Animal |products |( |meat, |poultry, |fish, |eggs,
|butter, |cheese, |whole |and |2% |milk)
Examples |of |foods |high |in |saturated |fatty |acids |- |ANSWER |high |fat |meats |(beef, |lamb, |pork, |poultry
|with |skin, |beef |fat, |lard), |dairy |products, |tropical |oils |( |palm |oil, |palm |kernel |oil, |coconut |oil)
Examples |of |foods |high |in |trans |fatty |acids |- |ANSWER |fried |foods, |baked |goods, |stick |margarines,
|shortenings
Examples |of |foods |high |in |monounsaturated |fatty |acids |- |ANSWER |vegetable |oils |(olive |oil, |canola |oil,
|peanut |oil, |sunflower |oil, |sesame |oil) |, |avocados, |peanutbutter, |nuts |and |seeds
solutions all verified and approved.
How |are |lipids |carried |- |ANSWER |on |lipoproteins |in |the |blood |because |they |are |insoluble |in |water
Proteins |found |on |lipoproteins |- |ANSWER |apolipoproteins
Density |of |lipoprotein |with |less |lipid |and |greater |protein |- |ANSWER |more |dense
Density |of |lipoprotein |with |more |lipids |and |less |protein |- |ANSWER |less |dense
Major |bloodstream |lipoproteins |- |ANSWER |chylomicrons, |vLDL, |LDL, |HDL
Chylomicrons |- |ANSWER |least |dense |of |the |lipoproteins |and |are |triglyceride-rich |particles |that |are
|formed |in |the |intestine
Function |of |Chylomicrons |and |where |they |can |be |found |- |ANSWER |Transport |dietary |fat |and |can |be
|found |in |the |bloodstream |at |highest |concentration |soon |after |a |meal
Least |to |most |dense |lipoprotein |particles |- |ANSWER |Chlyomicron, |vLDL, |LDL, |HDL
lipoprotein |that |is |the |most |atherogenic |of |all |lipoproteins |- |ANSWER |LDL
LDL |carries |- |ANSWER |60-70% |of |the |cholesterol |in |the |blood
HDL |carries |- |ANSWER |20-30% |of |the |cholesterol |in |the |blood
Equation |for |total |LDL-C |in |bloodstream |- |ANSWER |LDL= |TC-(HDL-C-(TG/5))
,When |does |calculating |LDL-C |become |inaccurate |- |ANSWER |when |TG |exceeds |400mg/dL
Desirable |total |cholesterol |level |- |ANSWER |<200
Borderline |high |total |cholesterol |level |- |ANSWER |200-240
High |total |cholesterol |level |- |ANSWER |>240
Optimal |TG |level |- |ANSWER |<150
Borderline |high |TG |level |- |ANSWER |150-199
High |TG |level |- |ANSWER |200-499
Very |high |TG |levels |- |ANSWER |>500
Optimal |in |men |HDL |levels |- |ANSWER |>40
Optimal |in |women |HDL |levels |- |ANSWER |>50
Optimal |LDL-C |levels |- |ANSWER |<100
Near |optimal |LDL-C |levels |- |ANSWER |100-129
Borderline |high |LDL-C |levels |- |ANSWER |130-159
,High |LDL-C |levels |- |ANSWER |160-189
Very |high |LDL-C |levels |- |ANSWER |>190
Hypertriglycerdemia |is |associated |with |high |levels |of |- |ANSWER |VLDL-C
Non-HDL-Cholesterol |calculation |- |ANSWER |HDL-C |- |Total |cholesterol
Atherogenic |dyslipidemia |- |ANSWER |Elevated |levels |of |TG, |low |HDL-C |and |only |modest |elevations |of
|LDL- |C
Metabolic |syndrome |- |ANSWER |requires |the |presence |of |any |3 |of |the |following |conditions: |abdominal
|obesity, |elevated |TG, |low |HDL, |elevated |BP |and |hyperglycemia
Criteria |for |metabolic |syndrome: |Abdominal |obesity |- |ANSWER |WC |>102 |cm |(40 |in) |for |men
WC |>88cm |(35 |in) |for |women
|
Criteria |for |metabolic |syndrome: |Hypertriglyceremia |- |ANSWER |≥150 |or |drug |treatment
Criteria |for |metabolic |syndrome: |Low |HDL |- |ANSWER |<40 |for |men
<50 |for |women
Criteria |for |metabolic |syndrome: |Elevated |BP |- |ANSWER |SBP
≥130 |DBP |≥85
|
or |drug |treatment
Criteria |for |metabolic |syndrome: |Hyperglycemia |- |ANSWER |Fasting |glucose |≥100
or |drug |treatment
|
, AACVPR |understanding |of |atherosclerosis |- |ANSWER |Traditional |risk |factors |are |a |source |of
|inflammatory |changes |in |the |blood |vessel |wall |--> |which |attract |lipid |laden |macrophages |and |other
|inflammatory |cells |to |enter |the |blood |vessel |wall |--> |where |they |proliferate |and |develop
|atherosclerotic |plaques |--> |which |are |the |source |of |the |clinical |manifestations |of |CHD
Fatty |streaks |- |ANSWER |lipid |deposition |(daily |lipid |laden |macrophages) |in |the |arterial |wall
Lumen |- |ANSWER |opening |inside |of |the |blood |vessel
fibrous |plaque |- |ANSWER |Larger |and |more |obstructive |lesoions |consisting |of |an |outer |fibrous
Why |do |plaque |ruptures |occurs |prior |to |the |development |of |cardiovascular |symptoms |in |many |cases |-
|ANSWER |Atherosclerotic |plaques |that |are |prone |to |rupture |tend |to |be |younger, |more |immature
|plaques |that |usually |do |not |produce |the |degree |of |luminal |narrowing |required |to |develop |exertion
|symptoms
What |occurs |after |a |plaque |rupture |- |ANSWER |Clot |formation |within |the |lumen |of |the |coronary
|artery, |potential |resulting |in |an |acute |coronary |syndrome |from |the |sudden |development |of |severe
|obstruction |to |coronary |blood |flow
Examples |of |foods |high |in |dietary |cholesterol |- |ANSWER |Animal |products |( |meat, |poultry, |fish, |eggs,
|butter, |cheese, |whole |and |2% |milk)
Examples |of |foods |high |in |saturated |fatty |acids |- |ANSWER |high |fat |meats |(beef, |lamb, |pork, |poultry
|with |skin, |beef |fat, |lard), |dairy |products, |tropical |oils |( |palm |oil, |palm |kernel |oil, |coconut |oil)
Examples |of |foods |high |in |trans |fatty |acids |- |ANSWER |fried |foods, |baked |goods, |stick |margarines,
|shortenings
Examples |of |foods |high |in |monounsaturated |fatty |acids |- |ANSWER |vegetable |oils |(olive |oil, |canola |oil,
|peanut |oil, |sunflower |oil, |sesame |oil) |, |avocados, |peanutbutter, |nuts |and |seeds
